InvestorsHub Logo
Followers 3
Posts 962
Boards Moderated 0
Alias Born 03/30/2021

Re: Blue Skys post# 5130

Sunday, 03/24/2024 10:16:53 AM

Sunday, March 24, 2024 10:16:53 AM

Post# of 5321
It almost "feels like" Mr Huemoeller and AXIM management are letting Verséa Ophthalmics tell the whole story about our products.

If I knew anything about charts (and I don't) the AXIM charts don't tell me anything about the recent sales. Daily charts: Not much but we do have higher volume over the last month. However the volume is similar to higher volume in the month of March in past years. Nothing stands out yet. Weekly charts? Monthly charts? Nothing. Just a downhill ski-slope. Maybe word of mouth travels slower on OTC? The recent volume might suggest we have a few more eyeballs, but not many. The dollar amount behind the volume is still a very small amount.

AXIM is still spending way too much money compared to sales revenue. Verséa Ophthalmics as well. Even with all of the recent sales activity it might still be possible for failure if sales don't materialize fast enough. Both companies are spending way too much money. Both companies desperately need CLIA waiver approvals NOW. Or last month or last year.



As for me, I have more AXIM shares right now than I ever thought possible a couple years ago. However my new money is chasing other things right now. I'm hoping to catch lightning in a bottle somewhere else for the next 4 or 5 months so l can decide in August 2024 if I want a lot bigger position in AXIM. That's my plan. Things could change. But if we only get one new customer per week it will take a long time for AXIM to be cash-flow positive.


Not investment advice.
Do your own research.
Don't invest money needed for food or rent or happiness.





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News